Table 3.
NRM | OS | ||||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
SCI score | |||||
0 | Reference | ||||
1 | 2.04 (1.11-3.74) | .021 | 1.71 (1.13-2.59) | .0105 | |
2 | 3.09 (1.66-5.73) | .000 | 2.6 (1.7-3.97) | <.001 | |
3 | 5.03 (2.64-9.6) | .000 | 3.15 (1.95-5.07) | <.001 | |
≥ 4 | 7.04 (3.61-13.73) | .000 | 4.08 (2.46-6.77) | 0 | |
Regimen | |||||
Melphalan-based | Reference | ||||
TBI-based | 0.89 (0.53-1.5) | .670 | 1.03 (0.71-1.49) | .888 | |
Karnofsky performance status | |||||
≤ 80 | Reference | ||||
90 − 100 | 1.53 (1.08-2.17) | .017 | 1.53 (1.17-2) | .002 | |
CIBMTR disease risk | |||||
Low/Intermediate | Reference | ||||
High | 1.05 (0.7-1.58) | .818 | 1.31 (0.97-1.76) | .078 | |
Unclassifiable | 0.57 (0.27-1.18) | .130 | 0.53 (0.28-0.98) | .042 | |
Recipient CMV serostatus | |||||
Negative | Reference | ||||
Positive | 1.13 (0.8-1.61) | .491 | 1.19 (0.91-1.57) | .197 | |
Donor type | |||||
Matched related | Reference | ||||
Matched unrelated | 1.1 (0.73-1.65) | .662 | 0.92 (0.68-1.24) | .590 | |
Mismatched | 2.4 (1.51-3.82) | .000 | 1.7 (1.19-2.42) | .003 |
CIBMTR, Center for International Blood and Marrow Transplant Research; CMV, cytomegalovirus.